Document Type : Research Articles
Authors
1
Quality and Accreditation Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
2
Nursing Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
3
Pharmacy Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
4
Holistic Care Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
5
Department of Urology Unit, Special Surgery, Faculty of Medicine, Mutah University, Karak, Jordan.
6
Research Center Amman, Jordan.
7
Medical Oncology Department, Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC), University Medical City, Muscat, Oman.
Abstract
Objective: Innovation culture plays a pivotal role in enhancing adaptability, care delivery, and strategic advancement in healthcare systems. Despite its critical importance, few validated instruments exist that are specifically tailored to measure innovation culture within healthcare organizations. This study aimed to develop and validate a 30-item Innovation Culture Scale, adapted for healthcare settings, especially oncology, capturing key organizational dimensions that influence innovation. Methods: A cross-sectional study was conducted in 2024 at the Sultan Qaboos Comprehensive Cancer Center (SQCCC), University Medical City, Muscat, Oman, involving 202 healthcare professionals. The questionnaire, grounded in the frameworks of Dobni (2008) and Tian et al. (2018), measured six latent constructs: Organizational Values and Culture, Leadership Behaviors, Resource Allocation, Innovation Processes, Organizational Climate, and Innovation Success. Psychometric assessments included descriptive statistics, internal consistency (Cronbach’s alpha), Confirmatory Factor Analysis (CFA), and convergent validity through average variance extracted (AVE). Model fit was assessed using CFI, TLI, RMSEA, SRMR, and χ²/df. Results: Mean item scores ranged from 3.68 to 3.91 (SD = 0.59–0.72), indicating moderate to strong agreement with the scale items. All items exhibited acceptable skewness (−0.28 to +0.18) and kurtosis (−0.66 to +0.28), with high internal consistency across constructs (Cronbach’s alpha = 0.831 to 0.884). CFA confirmed strong item loadings (>0.60), and the model demonstrated excellent fit: CFI = 0.962, TLI = 0.957, RMSEA = 0.042, SRMR = 0.035, and χ²/df = 1.87 (p = 0.062). AVE values ranged from 0.58 to 0.64, confirming convergent validity. Conclusion: The healthcare-adapted Innovation Culture Scale is a reliable and valid instrument for assessing innovation culture in clinical settings. Its application can support organizational assessment, leadership development, and strategic innovation planning aimed at enhancing quality, adaptability, and performance in oncology care.
Keywords
Main Subjects
)